Companies /Healthcare

Biomarin Pharmaceutical Inc

NASDAQ: BMRN Biotechnology
$61.42
▼ $0.01 (−0.02%) today
Markets closed · 5:26pm ET

BMRN Coverage Page 6

11:40am ET
Health and Healthcare

Why Credit Suisse Sees 25% Upside at BioMarin

BioMarin Pharmaceutical may have missed out on the Trump rally, but it might not be too late to catch a ride on the wave, at least according to one analyst.

Chris Lange